BPS Psychiatric Pharmacy Certification Examination Practice Test
Psychiatric pharmacy focuses on medication treatment for mental health conditions, including depression, bipolar disorder, and schizophrenia. Clinical decisions require matching medicines to symptoms and treatment history while accounting for adverse effects, interactions, laboratory monitoring, and changes in a patient’s health or daily routine.
Exam overview
About the BPS Psychiatric Pharmacy Certification Examination Exam
Psychiatric pharmacists assess whether medication exposure and timing support a sound treatment decision. For lithium, this includes interpreting concentrations in relation to the last dose and considering how changes in sodium intake may affect safety. For antidepressants, clinicians distinguish inadequate duration or dose from partial response, plan continuation after improvement when relapse risk matters, and address sexual adverse effects. Antipsychotic care involves recognizing movement disorders such as tardive dyskinesia, evaluating thirst and frequent urination for possible metabolic complications, and assessing orthostatic dizziness after dose changes. Across these situations, pharmacists reconcile prescriptions from multiple clinicians, identify interaction risks, and coordinate follow-up monitoring. The work combines symptom assessment, pharmacology, patient-specific risk evaluation, and communication with the broader care team to support effective and safer treatment.
Sample Practice Questions
Review a selection from this exam's published US Practice Tests practice bank.
A patient taking an antipsychotic for several years develops new repetitive lip smacking and tongue movements. Which management principle is most appropriate?
Show answer
Correct answer: ARepetitive orofacial movements after prolonged dopamine-receptor-blocking medication exposure raise concern for tardive dyskinesia. Assessment and review of the causative regimen are important; dose escalation may mask movements temporarily but is not an appropriate default strategy.
A patient taking lithium has a serum concentration that is higher than expected, but the sample was drawn two hours after the morning dose. What is the best next step for interpreting the concentration?
Show answer
Correct answer: ALithium concentrations are interpreted in relation to dose timing; a commonly used standardized measurement is obtained approximately 12 hours after the last dose. The patient's symptoms and safety still require clinical assessment, but a poorly timed result should not be treated as directly comparable to a standardized level.
A patient with bipolar disorder taking lithium begins a strict low-sodium diet after receiving dietary advice. What is a relevant concern for the care team to consider?
Show answer
Correct answer: AThe kidneys handle sodium and lithium in related ways. A substantial decrease in sodium intake can lead to greater renal reabsorption of lithium and potentially increase serum concentrations, so major dietary changes should be discussed and monitored clinically.
A patient taking an antidepressant is prescribed a new medication by another clinician. Which practice best reduces the chance of an avoidable drug interaction?
Show answer
Correct answer: AA complete and current medication list, including over-the-counter products and supplements, helps clinicians and pharmacists identify interactions and duplications. Patients should not independently stop established treatment when another medication is prescribed.
A patient with major depressive disorder has a history of several depressive episodes and asks why treatment may continue after symptoms improve. Which explanation is most accurate?
Show answer
Correct answer: AContinuation treatment after improvement can reduce relapse risk, particularly for people with recurrent episodes or other risk factors. Duration should be individualized with the prescriber; it is not necessarily lifelong, and treatment cannot guarantee that future episodes will not occur.
A patient with recurrent depression has taken an antidepressant consistently at a therapeutic dose for several weeks and reports only partial improvement. What is a reasonable next step before deciding the treatment has failed?
Show answer
Correct answer: AA partial response calls for reassessment of adherence, dose and duration, adverse effects, diagnosis, and relevant clinical factors. Subsequent optimization, switching, or augmentation should be individualized rather than decided by a single symptom report.
A patient with depression who has taken an SSRI for several months develops decreased sexual desire and difficulty reaching orgasm. Which approach is most appropriate as an initial clinical response?
Show answer
Correct answer: ASexual dysfunction can occur with SSRIs, but depression and other medical or medication factors may also contribute. A careful assessment and shared discussion can guide options such as dose adjustment, switching, or other strategies; abrupt discontinuation or unsupervised medication changes may cause harm.
How to use this practice test
The free practice bank contains 50 published questions. Each session presents up to 20 questions selected at random, with results shown after the session. Use the questions to identify which medication decisions need more review, such as lithium level interpretation, antidepressant response, adverse-effect assessment, or interaction prevention.
Preparation tips
- For lithium cases, connect concentration interpretation to sample timing, dose schedule, sodium intake, and relevant safety monitoring.
- When assessing antidepressant response, separate partial improvement from inadequate treatment exposure and consider tolerability and relapse-prevention needs.
- Review recognition and response to antipsychotic-associated tardive dyskinesia, orthostatic hypotension, and possible metabolic effects.
- Practice medication reconciliation across prescribers and identify how a newly added medicine could alter psychiatric drug exposure or safety.